Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | PRKCA | P17252 | 4/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13218896 | 0.94 | ALDH1A1 (0.59) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL14453250 | 0.94 | ALDH1A1 (0.59) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL16580778 | 0.91 | ALDH1A1 (0.51) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL406117 | 0.90 | PRKCA (0.63) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL13901129 | 0.87 | ADRA2A (0.59) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL16020426 | 0.83 | ALDH1A1 (0.47) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL21289215 | 0.83 | ALDH1A1 (0.70) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL19300633 | 0.83 | ALDH1A1 (0.70) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL17964469 | 0.82 | ALDH1A1 (0.41) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Tributyrin SCHEMBL601928 | 0.81 | ALDH1A1 (0.72) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237302-A1 | WATERBORNE COMPOSITIONS | CALLAGHAN INNOVATION RESEARCH LIMITED (NZ) | 2016-08-18 | — | — | US | disclosed |
| US-20160237302-A1 | WATERBORNE COMPOSITIONS | CALLAGHAN INNOVATION RESEARCH LIMITED (NZ) | 2016-08-18 | — | — | US | disclosed |
| WO-2015038012-A1 | WATERBORNE COMPOSITIONS | VICTORIA LINK LIMITED (NZ) | 2015-03-19 | — | — | WO | disclosed |
| US-8906961-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20130303648-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | GFBIOCHEMICALS LIMITED (MT) | 2013-11-14 | — | — | US | disclosed |
| US-8492433-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2013-07-23 | — | — | US | disclosed |
| EP-1954140-B1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS INC (US) | 2013-05-29 | — | — | EP | disclosed |
| US-20120196947-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | SEGETIS, INC. (US) | 2012-08-02 | — | — | US | disclosed |
| US-8178701-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS, INC. (US) | 2012-01-26 | — | — | US | disclosed |
| US-8053468-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2011-11-08 | — | — | US | disclosed |
| US-20100216915-A1 | Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-08-26 | — | — | US | disclosed |
| US-20100216915-A1 | Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-08-26 | — | — | US | disclosed |
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | AROMAGEN CORPORATION (US) | 2008-10-02 | — | — | US | disclosed |
| EP-1954140-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | Aromagen Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007094922-A2 | LEVULINIC ACID ESTER DERIVATIVES AS REACTIVE PLASTICIZERS AND COALESCENT SOLVENTS | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007062118-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | AROMAGEN CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216915-A1 | Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents | EPM2A, ALAD, GABRD | ALDH1A1 635/4885LMNA 908/4885PRKCA 176/4885 |
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | GK, FTO, DGKK | ALDH1A1 367/4885LMNA 1816/4885PRKCA 62/4885 |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | GK, GRIK5, KHK | ALDH1A1 815/4885LMNA 2269/4885PRKCA 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.